Quick Answer
ABBOTT LABORATORIES reported Net Income of $6.52 billion for fiscal year 2025.
ABBOTT LABORATORIES Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $6.52B | -51.3% |
| 2024 | $13.40B | +134.2% |
| 2023 | $5.72B | -17.5% |
| 2022 | $6.93B | -2.0% |
| 2021 | $7.07B | +57.3% |
| 2020 | $4.50B | +21.9% |
| 2019 | $3.69B | +55.7% |
| 2018 | $2.37B | +396.4% |
| 2017 | $477.00M | -65.9% |
| 2016 | $1.40B | -68.3% |
| 2015 | $4.42B | +93.7% |
| 2014 | $2.28B | -11.3% |
| 2013 | $2.58B | -56.8% |
| 2012 | $5.96B | +26.1% |
| 2011 | $4.73B | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.64B | -0.1% | -7.6% |
| June 30, 2025 | $1.78B | +36.6% | +34.3% |
| March 31, 2025 | $1.32B | +8.2% | -19.5% |
| September 30, 2024 | $1.65B | +14.6% | +26.4% |
| June 30, 2024 | $1.30B | -5.3% | +6.3% |
| March 31, 2024 | $1.23B | -7.1% | -14.7% |
| September 30, 2023 | $1.44B | +0.1% | +4.4% |
| June 30, 2023 | $1.38B | -31.9% | +4.3% |
- ABBOTT LABORATORIES showed a decrease of -51.3% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, ABBOTT LABORATORIES’s net income has grown by 38.0% (from $4.73 billion to $6.52 billion).
- The most recent figure is from ABBOTT LABORATORIES’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: